Shanghai Pharma, others in fray to buy US Cardinal Health's $1.5b China biz

Shanghai Pharma, others in fray to buy US Cardinal Health's $1.5b China biz

Shanghai Pharmaceuticals. Photo: Reuters

Julie Zhu, Kane Wu

20 July, 2017

Cardinal HealthChina Resources HoldingsChina Resources Pharmaceutical Group LtdLazardMedtronic PlcpharmaceuticalShanghai Pharmaceutical Holding Co LtdSinopharm Group Co Ltdstada

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter

Read more from Greater China

Nikkei Logo
DealStreetAsia Logo
About Us
Team
Advertise
Contact
Careers
Blog
Privacy Policy
Terms & Conditions
© Copyright DEALSTREETASIA 2014-2025 All rights reserved.